JOHANNESBURG, 2 October 2024 – CFAO Healthcare is pleased to announce its strategic expansion into the South African pharmaceutical market by acquiring Sanofi’s South African Consumer Healthcare business (Opella Healthcare South Africa), a prominent pharmaceutical manufacturer and distributor. It marks CFAO’s first healthcare investment in the country, which is the second-largest market on the Continent. The new entity will operate as CFAO Healthcare in South Africa.
CFAO Healthcare, a division of CFAO Group, continues its mission of enhancing healthcare globally by manufacturing, distributing, and providing pharmaceutical and medical products and related services. Now, with a presence in 28 countries, this acquisition further strengthens our position as the leading pan-African distributor of pharmaceutical products and sends a clear message about our seamless integration across every link in the value chain.
Read full press release, on this link
See also
